L Mastorino, L Burzi, G Frigatti, A Fazio… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Psoriasis affecting the genital, palmoplantar, and scalp regions is recognized as difficult-to-treat, and data on the efficacy of biologics in these areas remains limited …
G Becher, S Conner, JA Ingram, KE Stephen… - Dermatology and …, 2022 - Springer
Introduction As with most medicines historically, clinicians prescribing tildrakizumab have relied on information derived from registration studies undertaken in a prospective controlled …
R Salle, B Halioua, G Le Fur, R Aubert… - Skin Health and …, 2023 - Wiley Online Library
Abstract Background In France, psoriasis is a chronic inflammatory skin disease. For several years now, particular attention has been given to the quality of life (Qol) of psoriasis patients …
L Mastorino, V Celoria, N Macagno… - Dermatologic …, 2023 - Wiley Online Library
Introduction. Psoriasis of the scalp, genital areas, and palms and soles represents a treatment challenge in clinical practice. Randomized clinical trials and real‐life studies …
L Bettolini, S Bighetti, S Rovaris, M Arisi… - Journal of the …, 2024 - Wiley Online Library
Dear Editor, Genital psoriasis (GenPs) significantly impacts the quality of life (QoL), affecting both genders. 1 Secukinumab and ixekizumab, interleukin (IL)-17A inhibitors, have …